Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
Molecular Oncology
|
June 8, 2022
PGAM1 regulation of ASS1 contributes to the progression of breast cancer through the cAMP/AMPK/CEBPB pathway
Min Liu, Runmei Li, Min Wang, et al.
Cancer Immunology, Immunotherapy : CII
|
March 20, 2020
Identification and validation of tumor environment phenotypes in lung adenocarcinoma by integrative genome-scale analysis
Guoshu Bi, Zhencong Chen, Xiaodong Yang, et al.
Cancer Immunology, Immunotherapy : CII
|
May 15, 2012
Autologous cytokine-induced killer cell immunotherapy in lung cancer: a phase II clinical study
Runmei Li, Changli Wang, Liang Liu, et al.
Biosensors
|
October 28, 2025
Identification of Hybrid <i>Indica</i> Paddy Rice Grain Varieties Based on Hyperspectral Imaging and Deep Learning
Meng Zhang, Peng Li, Wei Dong, et al.
Journal of Translational Medicine
|
May 25, 2021
Pan-cancer characterization of metabolism-related biomarkers identifies potential therapeutic targets
Guoshu Bi, Yunyi Bian, Jiaqi Liang, et al.
BMC Cancer
|
October 30, 2024
First-line treatment with gefitinib in combination with bevacizumab and chemotherapy in advanced non-squamous NSCLC with EGFR-mutation
Yanjuan Xiong, Lu Wang, Weihong Zhang, et al.
Cancer Biology & Medicine
|
August 11, 2021
Ferritin as a diagnostic, differential diagnostic, and prognostic marker for immune-related adverse events
Weihong Zhang, Yuan Meng, Lin Yang, et al.
Annals of Translational Medicine
|
March 14, 2022
Safety and effectiveness of pembrolizumab combined with paclitaxel and cisplatin as neoadjuvant therapy followed by surgery for locally advanced resectable (stage III) esophageal squamous cell carcinoma: a study protocol for a prospective, single-arm, single-center, open-label, phase-II trial (Keystone-001)
Xiaobin Shang, Gang Zhao, Fei Liang, et al.
Frontiers in Immunology
|
May 10, 2017
Anti-CD47 Antibody As a Targeted Therapeutic Agent for Human Lung Cancer and Cancer Stem Cells
Liang Liu, Lin Zhang, Lin Yang, et al.
Cancer Immunology, Immunotherapy : CII
|
March 11, 2026
A single-arm phase Ib study of personalized peptide-pulsed dendritic cell-based multiple target cytotoxic T lymphocyte immunotherapy in combination with toripalimab as second-line therapy in advanced non-small-cell lung cancer
Weihong Zhang, Jing Qin, Jing Luo, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
Molecular Oncology
|
June 8, 2022
PGAM1 regulation of ASS1 contributes to the progression of breast cancer through the cAMP/AMPK/CEBPB pathway
Min Liu, Runmei Li, Min Wang, et al.
Cancer Immunology, Immunotherapy : CII
|
March 20, 2020
Identification and validation of tumor environment phenotypes in lung adenocarcinoma by integrative genome-scale analysis
Guoshu Bi, Zhencong Chen, Xiaodong Yang, et al.
Cancer Immunology, Immunotherapy : CII
|
May 15, 2012
Autologous cytokine-induced killer cell immunotherapy in lung cancer: a phase II clinical study
Runmei Li, Changli Wang, Liang Liu, et al.
Biosensors
|
October 28, 2025
Identification of Hybrid <i>Indica</i> Paddy Rice Grain Varieties Based on Hyperspectral Imaging and Deep Learning
Meng Zhang, Peng Li, Wei Dong, et al.
Journal of Translational Medicine
|
May 25, 2021
Pan-cancer characterization of metabolism-related biomarkers identifies potential therapeutic targets
Guoshu Bi, Yunyi Bian, Jiaqi Liang, et al.
BMC Cancer
|
October 30, 2024
First-line treatment with gefitinib in combination with bevacizumab and chemotherapy in advanced non-squamous NSCLC with EGFR-mutation
Yanjuan Xiong, Lu Wang, Weihong Zhang, et al.
Cancer Biology & Medicine
|
August 11, 2021
Ferritin as a diagnostic, differential diagnostic, and prognostic marker for immune-related adverse events
Weihong Zhang, Yuan Meng, Lin Yang, et al.
Annals of Translational Medicine
|
March 14, 2022
Safety and effectiveness of pembrolizumab combined with paclitaxel and cisplatin as neoadjuvant therapy followed by surgery for locally advanced resectable (stage III) esophageal squamous cell carcinoma: a study protocol for a prospective, single-arm, single-center, open-label, phase-II trial (Keystone-001)
Xiaobin Shang, Gang Zhao, Fei Liang, et al.
Frontiers in Immunology
|
May 10, 2017
Anti-CD47 Antibody As a Targeted Therapeutic Agent for Human Lung Cancer and Cancer Stem Cells
Liang Liu, Lin Zhang, Lin Yang, et al.
Cancer Immunology, Immunotherapy : CII
|
March 11, 2026
A single-arm phase Ib study of personalized peptide-pulsed dendritic cell-based multiple target cytotoxic T lymphocyte immunotherapy in combination with toripalimab as second-line therapy in advanced non-small-cell lung cancer
Weihong Zhang, Jing Qin, Jing Luo, et al.
Page
of 4